Floris Foijer

Floris Foijer
Groningen (NLD)


Dr. Floris Foijer has been working on genomic instability in cancer cells for many years. He obtained his PhD degree at the Netherlands Cancer Institute in Amsterdam in the lab of Prof. Hein te Riele in 2006. During his PhD, he identified a G2 phase checkpoint important for cell arrest and prevention of chromosomal instability.

As a postdoc, Floris Foijer joined the lab of Prof. Peter Sorger at Harvard Medical School in Boston, where he developed murine models for chromosomal instability. In pursuit of more sophisticated mouse models, he shifted to the lab of Prof. Allan Bradley at the Wellcome Trust Sanger Institute in Cambridge, UK, where he engineered a murine model for tracking chromosomal instability over time.

Since December 2011, he has been the leader of the “Genomic Instability in Development and Disease” group at the European Institute for the Biology of Ageing (ERIBA) in Groningen, the Netherlands. His lab focuses on the in vivo consequences of chromosomal instability, especially on mechanisms of aneuploidy and new therapies for aneuploid cancers.

Latest News


Workshop Registration for HFYLS 5 paticipants is possible from now on. Places are limited and will be assigned on a first-come-first-serve basis.




Join us now on